High Flow Nasal Cannula Oxygen During Sedation for Video-assisted Thoracoscopic Surgery
NCT ID: NCT04520568
Last Updated: 2020-08-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2
60 participants
INTERVENTIONAL
2020-08-01
2020-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Identifying the Best Flow Setting Strategy for High-Flow Nasal Cannula
NCT07007715
High Flow Nasal Cannula Versus Non-Invasive (NIV)in Both Hypoxemic and Hypercapnic Respiratory Failure.
NCT05499039
The Effects of Flow Settings During High Flow Nasal Cannula for Adult Hypoxemia Patients
NCT03738345
Asymmetrical HFNCO vs Standard HFNCO Post Cardiac Surgery Patients
NCT06521489
High Flow Nasal Cannula With Noninvasive Ventilation
NCT04507425
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HFNC group
For HFNC group, F\&P AIRVOTM 2 will be adjusted to give the patients the oxygen flow at 50L/min and the FiO2 at 1.0.Then after three minutes of preoxygenation, sedation will be conducted by giving 25 µg fentanyl and a bolus of 1 mg/kg propofol followed by continuous infusion of propofol using a target-controlled infusion system (TCI pump TE371; Terumo Corporation, TokyoJapan).
High flow nasal cannula
using sedation with the HFNC F\&P AIRVOTM 2 to maintain oxygenation
control group
induction of general anaesthesia will be done using 2 mg/kg propofol and 1 µg/kg fentanyl. Double lumen tube will be facilitated by cisatracurium 0.2 mg/kg. Anaesthesia will be maintained with isoflurane 0.8 %-1% in 100% oxygen and maintenance dose of cisatracurium 0.02 mg/kg when needed. At the end of surgery, residual neuromuscular paralysis will be antagonized with neostigmine 0.05 mg/kg and atropine 0.01 mg/kg.
CONTROL
using general anaesthesia with one lung ventilation (OLV) technique
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High flow nasal cannula
using sedation with the HFNC F\&P AIRVOTM 2 to maintain oxygenation
CONTROL
using general anaesthesia with one lung ventilation (OLV) technique
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* undergoing VATS
Exclusion Criteria
* extrem of age
30 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alexandria University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
rehab zayed
Assisstant Professor of Anesthesia
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rehab A. Abd Elaziz, Ass.Prof.
Role: PRINCIPAL_INVESTIGATOR
Alexandria University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rehab Abd Elraof Abd Elaziz
Alexandria, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0304712
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.